Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 6-K, Date: 2018-03-12
Original SEC Filing: Click here

---

Webplus: KANG/20180312/6-K/2_EX-99.1/000.htm SEC Original: a18-8064_1ex99d1.htm
iKang Announces Receipt of Proposal from Yunfeng Capital and Alibaba BEIJING, March 12, 2018 (GLOBE NEWSWIRE) — iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), The Special Committee has received a proposal from Yunfeng and Alibaba Investment Limited (“Alibaba”), proposing a transaction in which a consortium led by Yunfeng and Alibaba would acquire all of the outstanding Class

---

---

Webplus: KANG/20180312/6-K/1/000.htm SEC Original: a18-8064_16k.htm
IKANG HEALTHCARE GROUP, INC. Yang Chen Chief Financial Officer 2

---

Company Info:

Ticker: KANG, Company: iKang Healthcare Group, Inc., Type: 6-K, Date: 2018-03-12CIK: 0001524190, Location: F4, SIC: 8011, SIC Desc: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
Business Phone & Address:
B-6F, SHIMAO TOWER, 92A JIANGUO ROAD, CHAOYANG DISTRICT
Beijing 100022